The Latest Cardiac and Vascular News
VANCOUVER and MINNEAPOLIS, Dec. 10, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX:NVCN), announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum market value requirement set forth […]
WEBSTER, Texas, Dec. 10, 2020 /PRNewswire/ — EverHeart Systems – developer of fully implanted mechanical circulatory support devices – announced today that it has changed its corporate name to Corvion, Inc. The name change has been chosen to further differentiate the Company’s products and mission from others in the mechanical circulatory assist device field […]
IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance today during its annual investor conference. Highlights1 of today’s conference include: Presenting long-term strategic initiatives and growth outlook Projecting 2021 global sales […]
Eliminates long-term debt with flexibility of a new term loan commitment to fund future expansion, if needed MONMOUTH JUNCTION, N.J., Dec. 10, 2020 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces it has […]
Prairie Village, KS – December 8, 2020 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the appointment of John Ayres to the position of Vice President of Corporate Development and General Counsel. Mr. Ayres comes to […]
SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced Venita Chandra, M.D., will join the company’s scientific advisory board. Dr. Chandra is board certified in both general and vascular surgery. She is a clinical associate professor of surgery […]
VANCOUVER and MINNEAPOLIS, MN, Dec. 08, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc.(“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 6,230,803 common shares at a purchase price of US$0.9801 per common […]
KYOTO, Japan, Nov. 24, 2020 /PRNewswire/ — OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram (ECG) technology. OMRON led this round of investment, reinforcing the cross-company collaboration that began in 2017. The companies continue to […]
OXFORD, England, Dec. 7, 2020 /PRNewswire/ — GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease announces today the appointment of Paul Foulger as Chief Financial Officer to the Company. Paul Foulger is an experienced CFO with a proven, demonstrable track record in the Biotech industry for both […]
Contour Therapeutics Brings Together Leaders with Extensive Cardiovascular, Genetics and Drug Development Expertise Partnership Focused on Delivering Targeted Therapies for Genetically Defined Cardiovascular Diseases PALO ALTO, Calif. and SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) and Maze Therapeutics today announced the establishment of a joint venture, Contour Therapeutics, focused […]
